PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 2004; 97(Suppl 44): 60–71.
PMCID: PMC1308802

Potential benefits of the UK Cystic Fibrosis Database.

Full Text

The Full Text of this article is available as a PDF (2.1M).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Dodge JA, Morison S, Lewis PA, Coles EC, Geddes D, Russell G, Littlewood JM, Scott MT. Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee. Arch Dis Child. 1997 Dec;77(6):493–496. [PMC free article] [PubMed]
  • McCormick Jonathan, Green Michael W, Mehta Gita, Culross Frank, Mehta Anil. Demographics of the UK cystic fibrosis population: implications for neonatal screening. Eur J Hum Genet. 2002 Oct;10(10):583–590. [PubMed]
  • Robson M, Abbott J, Webb K, Dodd M, Walsworth-Bell J. A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients. Thorax. 1992 Sep;47(9):684–689. [PMC free article] [PubMed]
  • Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, Hoffman G, Laessig RH, Splaingard ML. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics. 2001 Jan;107(1):1–13. [PubMed]
  • Waters DL, Wilcken B, Irwing L, Van Asperen P, Mellis C, Simpson JM, Brown J, Gaskin KJ. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed. 1999 Jan;80(1):F1–F7. [PMC free article] [PubMed]
  • Mehta A. Further comments on fibrosing colonpathy study. Lancet. 2001 Nov 3;358(9292):1546–1548. [PubMed]
  • Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583–591. [PubMed]
  • Ratjen Felix, Döring Gerd. Cystic fibrosis. Lancet. 2003 Feb 22;361(9358):681–689. [PubMed]
  • Groman Joshua D, Meyer Michelle E, Wilmott Robert W, Zeitlin Pamela L, Cutting Garry R. Variant cystic fibrosis phenotypes in the absence of CFTR mutations. N Engl J Med. 2002 Aug 8;347(6):401–407. [PubMed]
  • Mekus F, Ballmann M, Bronsveld I, Dörk T, Bijman J, Tümmler B, Veeze HJ. Cystic-fibrosis-like disease unrelated to the cystic fibrosis transmembrane conductance regulator. Hum Genet. 1998 May;102(5):582–586. [PubMed]
  • Rosenstein Beryl J. Nonclassic cystic fibrosis: a clinical conundrum. Pediatr Pulmonol. 2003 Jul;36(1):10–12. [PubMed]
  • Fogarty A, Hubbard R, Britton J. International comparison of median age at death from cystic fibrosis. Chest. 2000 Jun;117(6):1656–1660. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press